Login
With over 20 years of relevant market insights and forecasting experience, Steve has held progressive positions in Market Insights and Forecasting with Ipsen Pharmaceuticals, Pfizer (Warner-Lambert), and Novartis (Sandoz). More recently Steve was the Senior Director, Global Strategic Market insights for Takeda Oncology. As part of this role, he personally provided insights covering new products and the in-licensing and launch of ADCETRIS (brentuximab vedotin) , and he evolved his department’s focus from a US-only to a global one.
Steve gained much of his experience through countless projects in oncology, hematology, neurology, endocrinology, and other specialty areas. His expertise covers market understanding (e.g., market landscape, Read more
Market Insights and New Product Analyses:
• Primary & Secondary Market Insights including Project Management, Fieldwork, and Reporting
• Due Diligence Product & Market Evaluations
• Key opinion leader (KOL), Specialist, HCP, & Patient Perspectives
Forecasting:
• Assumption Analysis through Primary and Secondary Market Research
• Model Development, both Global and Domestic
• Methodologies to address both Pipeline & In-Line Products
Recent engagements supporting the following firms:
• Apricus Biosciences
• Avanir Pharmaceuticals
• Bayer
• Genentech
• Impact-XM
• Janssen
• Merck
• Neurocrine Biosciences
• Otsuka
• Pharmacyclics
• Regeneron
• Sanofi
• Sutro Biopharma
• Takeda
• ZS Pharmaceuticals
